Gov. Abbott signs Texas Women's Privacy Act into law News Earlier Monday, Gov. Greg Abbott signed the Texas Women's Privacy Act. The law requires people to use the bathroom that matches their sex ...
Abbott Laboratories and Dexcom are the biggest players in the market for continuous glucose monitoring devices. Abbott has a vast lineup of products beyond that and an overall diversified healthcare ...
City of Dallas says its committed to complying with state laws as Abbott threatens funding To stream WFAA on your phone, you need the WFAA app.
Abbott (ABT) trades at $100.69 with a 24/7 Wall St. price target of $125.10 (24.24% upside) on a buy recommendation with 90% confidence. FreeStyle Libre CGM sales hit $2B in Q4 2025 with 15% year-over ...
Abbott Laboratories shares are down about 6% after the medical devices and nutrition company gave a 2026 forecast that disappointed analysts. In its first quarter report released Thursday, analysts ...
Hosted on MSN
Why Abbott Laboratories stock tumbled on Thursday
Investors had more of an issue with guidance. The company cut its full-year forecast for adjusted profitability. 10 stocks we like better than Abbott Laboratories › Abbott Laboratories (NYSE: ABT) ...
Investors had more of an issue with guidance. The company cut its full-year forecast for adjusted profitability. In the quarter, Abbott's sales totaled just under $11.2 billion, nearly 8% higher year ...
This call is being recorded by Abbott. With the exception of any participant's questions asked during the question-and-answer session, the entire call, including the question-and-answer session, is ...
Abbott Laboratories (ABT) and exchange traded funds with significant exposure to the healthcare company drew investor attention Thursday after the stock declined 4.5% following its latest earnings ...
Abbott Laboratories ABT0.85%increase; green up pointing triangle cut its full-year earnings outlook to account for a recent acquisition and said a weaker-than-expected flu season hurt its recent ...
April 16 (Reuters) - Abbott Laboratories (ABT.N), opens new tab won the dismissal of a proposed class action by parents who alleged its Similac infant formula contained undisclosed heavy metals. In a ...
Abbott Laboratories cut its full-year earnings outlook to account for a recent acquisition and said its nutrition unit continued to notch soft sales during the first quarter. The company, which sells ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results